UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 8, 2026
Sale
Calculated transaction value
$95.52K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 7, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$545
Oct 7, 2026
First close after public filing
$546.94
Oct 9, 2026
Return after filing · so far
0.0%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 176 shares @ $542.73
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000159
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.33M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Oct 7, 2026 | $1.12M |
| United Therapeutics Corp UTHR Current | Sale | Oct 7, 2026 | $95.52K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $404.56K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $1.14M |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $269.1K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $344.03K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $212.14K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $644.13K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $480.82K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $267.83K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $243.01K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $102.43K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $268.94K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $516.87K |
| United Therapeutics Corp UTHR | Sale | Oct 7, 2026 | $222.59K |